BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 10338873)

  • 1. FDA plan for statutory compliance. Notice of availability.
    Fed Regist; 1998 Nov; 63(226):65000-40. PubMed ID: 10338873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice.
    Fed Regist; 1998 May; 63(99):28388-91. PubMed ID: 10179874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administrative practices and procedures; internal agency review of decisions--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Sep; 63(184):50757. PubMed ID: 10185804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(92):26690-3. PubMed ID: 10179340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; immunology and microbiology devices; classification of the endotoxin assay. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(211):62007-8. PubMed ID: 14594019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
    Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; immunology and microbiology devices; classification of the immunomagnetic circulating cancer cell selection and enumeration system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 May; 69(91):26036-8. PubMed ID: 15137395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; general and plastic surgery devices; classification of the low energy ultrasound wound cleaner. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(214):67353-5. PubMed ID: 16273747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of regulations regarding certification of antibiotic drugs; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(91):26127-9. PubMed ID: 10179335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; ear, nose, and throat devices; classification of the transcutaneous air conduction hearing aid system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Nov; 67(216):67789-90. PubMed ID: 12422884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; obstetrical and gynecological devices; classification of the breast lesion documentation system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jul; 68(144):44413-5. PubMed ID: 12884877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of regulations regarding certification of antibiotic drugs--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26066-9. PubMed ID: 10179333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Year 2000 (Y2K) computer compliance guide; guidance for FDA personnel. Food and Drug Administration. Notice.
    Fed Regist; 1999 May; 64(93):26424-6. PubMed ID: 10558534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; reclassification of the cutaneous carbon dioxide and the cutaneous oxygen monitor. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Dec; 67(240):76678-81. PubMed ID: 12481766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA Modernization Act of 1997: modifications to the list of recognized standards; availability; withdrawal of draft guidance "Use of IEC 60601 standards; medical electrical equipment"--FDA. Notice.
    Fed Regist; 1998 Oct; 63(200):55617-30. PubMed ID: 10185835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; immunology and microbiology devices; classification of the West Nile Virus IgM capture Elisa assay. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(210):61743-5. PubMed ID: 14587527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology and Microbiology Devices; Classification of Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Test Systems. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(226):70305-7. PubMed ID: 11503713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.